Literature DB >> 32563052

Proceedings of the 15th Antiepileptic Drug and Device Trials Meeting: State of the Science.

Christina M Boada1, Jacqueline A French1, Sonya B Dumanis2.   

Abstract

On May 22-24, 2019, the 15th Antiepileptic Drug and Device (AEDD) Trials Conference was held, which focused on current issues related to AEDD development from preclinical models to clinical prognostication. The conference featured regulatory agencies, academic laboratories, and healthcare companies involved in emerging epilepsy therapies and research. The program included discussions around funding and support for investigations in epilepsy and neurologic research, clinical trial design and integrated outcome measures for people with epilepsy, and drug development and upcoming disease-modifying therapies. Finally, the conference included updates from the preclinical, clinical, and device pipeline. Summaries of the talks are provided in this paper, with the various pipeline therapeutics in the listed tables to be outlined in a subsequent publication.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Devices; Diagnostics; Epilepsy; Seizure; Therapeutics; Therapies

Year:  2020        PMID: 32563052     DOI: 10.1016/j.yebeh.2020.107189

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  2 in total

Review 1.  Experimental GABA A Receptor Agonists and Allosteric Modulators for the Treatment of Focal Epilepsy.

Authors:  Slobodan M Janković; Miralem Dješević; Snežana V Janković
Journal:  J Exp Pharmacol       Date:  2021-03-08

Review 2.  The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond.

Authors:  Wolfgang Löscher; Pavel Klein
Journal:  CNS Drugs       Date:  2021-06-18       Impact factor: 5.749

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.